LOS ANGELES (CN) - A class action claims the Obesity Research Institute pushes its "Lipozene" drug with false claims that it is a "miracle ... weight loss breakthrough" that "is clinically proven" to "cause rapid and substantial weight loss without the need of diet and exercise." Obesity allegedly claims, falsely, that Lipozene will "attack just the fat" and that 78% of all the weight lost is "pure body fat."
"In point of fact, Lipozene is nothing more than a fiber pill that has no weight loss properties," the class claims in Superior Court. It says Henry den Uijl founded the defendants company in 2003 in California.
Plaintiffs are represented by Milstein, Adelman & Kreger.
Read the Top 8
Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.
Additional Reads
-
Weight Loss Drug a 'Game Changer' in Cutting Obesity: Study February 11, 2021 -
Severely Obese Kids Should Consider Surgery, Doctors Say October 28, 2019
-
Cholesterol Down With Extra Poundage, Trump Now Obese February 15, 2019 -
Snake Oil March 30, 2016